Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.
10.1038/s41467-018-06300-3 Paulson et al. Nat Commun Cited 3 times
Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N, Thomas H, Colunga AG, Iyer JG, Yee C, Kulikauskas R, Koelle DM, Pierce RH, Bielas JH, Greenberg PD, Bhatia S, Gottardo R, Nghiem P, Chapuis AG
Study details